Is concordance the primrose path to health?

British Medical Journal

Volumn 327, Issue 7419, 2003, Pages 821-822

  Ferner, Robin E ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHADONE;

BANGLADESH; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DECISION MAKING; DOCTOR PATIENT RELATION; EDITORIAL; HUMAN; HYPERTENSION; MEDICAL CARE; MEDICAL ETHICS; META ANALYSIS; NEW ZEALAND; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TUBERCULOSIS; UNITED KINGDOM; UNITED STATES; WORLD HEALTH ORGANIZATION; FAMILY; HEALTH STATUS; PATIENT PARTICIPATION; PROFESSIONAL PATIENT RELATIONSHIP; RISK ASSESSMENT; RISK FACTOR;

PROFESSIONAL PATIENT RELATIONSHIP;

FAMILY; HEALTH STATUS; HUMANS; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; PRESCRIPTIONS, DRUG; RISK ASSESSMENT; RISK FACTORS;

EID: 0142009570     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7419.821     Document Type: Editorial

References (15)

1. Concordance Co-ordinating Group. Concordance - partnership in medicine taking, information pack. London: Royal Pharmaceutical Society of Great Britain, 2000.
2. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462-7.
3. World Health Organization. Chapter 3. Perceiving risk. In: World Health Report 2002. Geneva: WHO, 2003.
4. Ho M, Pullar T. Risk taking in patients with rheumatoid arthritis. Rheumatology 2000;39:80.
5. Mulrow C, Lau J, Cornell J, Brand M. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2000;(2):CD000028.
6. Kessels RPC. Patients' memory for medical information. J R Soc Med 2003;96:219-22.
7. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2003;(2):CD001431.
8. Estrada CA, Hryniewicz MM, Higgs VB, Collins C, Byrd JC. Anticoagulant patient information material is written at high readability levels. Stroke 2000;31:2966-70.
9. Kastrissios H, Blaschke TF. Medication compliance as a feature in drug development. Annu Rev Pharmacol Toxicol 1997;37:451-75.
10. Hughes DA, Walley T. Predicting "real world" effectiveness by integrating adherence with pharmacodynamic modeling. Clin Pharm Ther 2003;74:1-7.
11. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment Br J Clin Pharmacol 2000;50:166-71.
12. Hatton MQ, Allen MB, Vathenen SV, Feely MP, Cooke NJ. Compliance with oral corticosteroids during steroid trials in chronic airways obstruction. Thorax 1996;51:323-4.
13. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV, and members of the Infection Control Programme. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307-12.
14. Dichter E. The strategy of desire. London: TV Boardman. 1960.
15. Toop L, Richards D, Dowell T, Tilyard M, Fraser T, Arroll B. Direct to consumer advertising of prescription drugs in New Zealand: for health or for profit? Report to the minister of health supporting the case for a ban on DTCA. Christchurch: University of Otago, 2003.